Cargando…

Heterologous vaccine regimens against COVID-19

Detalles Bibliográficos
Autores principales:	Duarte-Salles, Talita, Prieto-Alhambra, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233006/ https://www.ncbi.nlm.nih.gov/pubmed/34181881 http://dx.doi.org/10.1016/S0140-6736(21)01442-2

Ejemplares similares

Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain
por: Roel, Elena, et al.
Publicado: (2022)

Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
por: Parker, Edward P K, et al.
Publicado: (2022)

Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19
por: Richardson, Christopher D
Publicado: (2021)

Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older
por: Iversen, Patrick L, et al.
Publicado: (2021)

An issue of trust—vaccinating Black patients against COVID-19
por: Okorodudu, Dale O, et al.
Publicado: (2021)

Offline: Preparing for a vaccine against COVID-19
por: Horton, Richard
Publicado: (2020)

DNA vaccines join the fight against COVID-19
por: Blakney, Anna K, et al.
Publicado: (2022)

Responsive and agile vaccination strategies against COVID-19 in India
por: Mandal, Sandip, et al.
Publicado: (2021)

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation
Publicado: (2020)

A rationale to prioritise vaccination of HSCT patients against COVID-19
por: Leclerc, Mathieu, et al.
Publicado: (2021)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19
por: Richardson, Christopher D
Publicado: (2022)

Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic
por: Salles, Arghavan, et al.
Publicado: (2021)

The natural history of symptomatic COVID-19 during the first wave in Catalonia
por: Burn, Edward, et al.
Publicado: (2021)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
por: Burn, Edward, et al.
Publicado: (2022)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

Protection against COVID-19: beyond antibodies
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2022)

Vaccine Verification in the COVID-19 World
por: Salmon, Daniel A., et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
por: Li, Xintong, et al.
Publicado: (2022)

Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a cohort study of 2 524 926 Catalans
por: Recalde, Martina, et al.
Publicado: (2021)

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Putman, Michael, et al.
Publicado: (2022)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain
por: Burn, Edward, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

Does Smoking Protect against Being Hospitalized for COVID-19?
por: Berlin, Ivan, et al.
Publicado: (2020)

Challenges in the Development of a Vaccine Against COVID-19
por: Chen, Wei, et al.
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19
por: Li, Jing-Xin, et al.
Publicado: (2021)

Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy
por: Scoccianti, Silvia, et al.
Publicado: (2021)

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
por: Møller Kirsebom, Freja Cordelia, et al.
Publicado: (2022)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom
por: Burn, Edward, et al.
Publicado: (2022)

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Are COVID-19 vaccines safe in pregnancy?
por: Male, Victoria
Publicado: (2021)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

COVID-19 vaccines and women's security
por: Harman, Sophie, et al.
Publicado: (2021)

Modelling vaccination strategies for COVID-19
por: Wagner, Caroline E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_saqehonodc4ktrpf9g70idsmsg